|
111
|
336
|
4o21A |
Product complex of metal-free pkac, atp-gamma-s and sp20. |
|
92
|
293
|
4nfmA |
Human tau tubulin kinase 1 (ttbk1) |
|
72
|
266
|
4o0sA |
Crystal structures of human kinase aurora a |
|
103
|
349
|
4n4sA |
A double mutant rat erk2 in complex with a pyrazolo[3,4-d]pyrimidine inhibitor |
|
72
|
266
|
4o0uA |
Crystal structures of human kinase aurora a |
|
97
|
309
|
4nw6A |
Rsk2 n-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27 |
|
106
|
378
|
4nu1A |
Crystal structure of a transition state mimic of the gsk-3/axin complex bound to phosphorylated n-terminal auto-inhibitory ps9 peptide |
|
87
|
277
|
4o2pA |
Kinase domain of csrc in complex with a substituted pyrazolopyrimidine |
|
87
|
302
|
4nk9A |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1 |
|
81
|
298
|
4nj3A |
Modulating the interaction between cdk2 and cyclin a with a quinoline-based inhibitor |
|
78
|
248
|
4o4eA |
Crystal structure of an inositol hexakisphosphate kinase ehip6ka in complexed with atp and ins(1,3,4,5,6)p5 |
|
79
|
275
|
4n70A |
Pim1 complexed with a pyridylcarboxamide |
|
154
|
465
|
4mx9A |
Cdpk1 from neospora caninum in complex with inhibitor uw1294 |
|
86
|
298
|
4nksA |
Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3 |
|
95
|
306
|
4o91A |
Crystal structure of type ii inhibitor ng25 bound to tak1-tab1 |
|
113
|
352
|
4nifB |
Heterodimeric structure of erk2 and rsk1 |
|
90
|
263
|
4otqA |
Crystal structure of btk kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea |
|
87
|
293
|
4o0rA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
98
|
331
|
4nstA |
Crystal structure of human cdk12/cyclin k in complex with adp-aluminum fluoride |
|
108
|
361
|
4nm5A |
Crystal structure of gsk-3/axin complex bound to phosphorylated wnt receptor lrp6 c-motif |
|
47
|
163
|
4o96A |
2.60 angstrom resolution crystal structure of a protein kinase domain of type iii effector nleh2 (ecs1814) from escherichia coli o157:h7 str. sakai |
|
109
|
346
|
4nctC |
Human dyrk1a in complex with pkc412 |
|
84
|
273
|
4n6zA |
Pim1 complexed with a pyridylcarboxamide |
|
84
|
292
|
4o0tA |
Back pocket flexibility provides group-ii pak selectivity for type 1 kinase inhibitors |
|
85
|
343
|
4ntsA |
Apo structure of the catalytic subunit of camp-dependent protein kinase |
|
96
|
330
|
4nh1A |
Crystal structure of a heterotetrameric ck2 holoenzyme complex carrying the andante-mutation in ck2beta and consistent with proposed models of autoinhibition and trans-autophosphorylation |
|
77
|
240
|
4o4dA |
Crystal structure of an inositol hexakisphosphate kinase ehip6ka in complexed with atp and ins(1,4,5)p3 |
|
112
|
347
|
4nctA |
Human dyrk1a in complex with pkc412 |
|
97
|
336
|
4otdA |
Crystal structure of prk1 catalytic domain |
|
221
|
708
|
4o1oA |
Crystal structure of rnase l in complex with 2-5a |
|
86
|
302
|
4nt4A |
Crystal structure of the kinase domain of gilgamesh isoform i from drosophila melanogaster |
|
80
|
279
|
4o6lA |
Crystal structure of ttk kinase domain with an inhibitor: 401498 (n-[(1r)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1h-indazole-5-carboxamide) |
|
80
|
250
|
4o4bB |
Crystal structure of an inositol hexakisphosphate kinase ehip6ka as a fusion protein with maltose binding protein |
|
66
|
268
|
4otpA |
Crystal structure of the catalytic domain of the human riok1 atypical protein kinase in complex with adp/mg2+ |
|
111
|
329
|
4oucA |
Structure of human haspin in complex with histone h3 substrate |
|
88
|
335
|
4otiA |
Crystal structure of prk1 catalytic domain in complex with tofacitinib |
|
82
|
277
|
4mxoA |
Human src kinase bound to kinase inhibitor bosutinib |
|
147
|
455
|
4mvfA |
Crystal structure of plasmodium falciparum cdpk2 complexed with inhibitor staurosporine |
|
79
|
277
|
4mxzA |
Src m314l t338m double mutant bound to kinase inhibitor bosutinib |
|
79
|
277
|
4mxyA |
Src m314l t338m double mutant bound to kinase inhibitor bosutinib |
|
98
|
295
|
4mxcA |
Crystal structure of cmet in complex with novel inhibitor |
|
155
|
465
|
4mxaA |
Cdpk1 from neospora caninum in complex with inhibitor rm-1-132 |
|
84
|
264
|
4m12A |
Crystal structure of itk in complex with compound 7 [4-(carbamoylamino)-1-(7-ethoxynaphthalen-1-yl)-1h-pyrazole-3-carboxamide] |
|
122
|
346
|
4mq1A |
The crystal structure of dyrk1a with a bound pyrido[2,3-d]pyrimidine inhibitor |
|
77
|
274
|
4mneB |
Crystal structure of the braf:mek1 complex |
|
77
|
298
|
4lynA |
Crystal structure of cyclin-dependent kinase 2 (cdk2-wt) complex with (2s)-n-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3-thiazol-2-yl)-2-phenylpropanamide |
|
110
|
332
|
4md7E |
Crystal structure of full-length symmetric ck2 holoenzyme |
|
51
|
163
|
4lrjA |
Bacterial effector nleh1 kinase domain with amppnp and mg2+ |
|
77
|
273
|
4medA |
Crystal structure of ser/thr kinase pim1 in complex with thioridazine derivatives |
|
114
|
351
|
4lopA |
Structural basis of autoactivation of p38 alpha induced by tab1 (tetragonal crystal form) |
